570 related articles for article (PubMed ID: 30787925)
1. The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity.
Van Herck MA; Weyler J; Kwanten WJ; Dirinck EL; De Winter BY; Francque SM; Vonghia L
Front Immunol; 2019; 10():82. PubMed ID: 30787925
[TBL] [Abstract][Full Text] [Related]
2. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis.
Chackelevicius CM; Gambaro SE; Tiribelli C; Rosso N
World J Gastroenterol; 2016 Nov; 22(41):9096-9103. PubMed ID: 27895397
[TBL] [Abstract][Full Text] [Related]
3. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.
He B; Wu L; Xie W; Shao Y; Jiang J; Zhao Z; Yan M; Chen Z; Cui D
BMC Immunol; 2017 Jun; 18(1):33. PubMed ID: 28646856
[TBL] [Abstract][Full Text] [Related]
4. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).
Nati M; Haddad D; Birkenfeld AL; Koch CA; Chavakis T; Chatzigeorgiou A
Rev Endocr Metab Disord; 2016 Mar; 17(1):29-39. PubMed ID: 26847547
[TBL] [Abstract][Full Text] [Related]
5. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.
Rolla S; Alchera E; Imarisio C; Bardina V; Valente G; Cappello P; Mombello C; Follenzi A; Novelli F; Carini R
Clin Sci (Lond); 2016 Feb; 130(3):193-203. PubMed ID: 26558403
[TBL] [Abstract][Full Text] [Related]
6. The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.
Sutti S; Bruzzì S; Albano E
Expert Rev Gastroenterol Hepatol; 2016; 10(2):243-53. PubMed ID: 26634783
[TBL] [Abstract][Full Text] [Related]
7. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
8. Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells.
Zhang F; Jiang WW; Li X; Qiu XY; Wu Z; Chi YJ; Cong X; Liu YL
J Dig Dis; 2016 Jul; 17(7):464-74. PubMed ID: 27216040
[TBL] [Abstract][Full Text] [Related]
9. B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).
Bruzzì S; Sutti S; Giudici G; Burlone ME; Ramavath NN; Toscani A; Bozzola C; Schneider P; Morello E; Parola M; Pirisi M; Albano E
Free Radic Biol Med; 2018 Aug; 124():249-259. PubMed ID: 29920340
[TBL] [Abstract][Full Text] [Related]
10. Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.
Cairoli V; De Matteo E; Rios D; Lezama C; Galoppo M; Casciato P; Mullen E; Giadans C; Bertot G; Preciado MV; Valva P
Sci Rep; 2021 Mar; 11(1):5129. PubMed ID: 33664397
[TBL] [Abstract][Full Text] [Related]
11. Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.
Vasseur P; Dion S; Filliol A; Genet V; Lucas-Clerc C; Jean-Philippe G; Silvain C; Lecron JC; Piquet-Pellorce C; Samson M
Oncotarget; 2017 Jul; 8(30):48563-48574. PubMed ID: 28611297
[TBL] [Abstract][Full Text] [Related]
12. Murine CD103
Heier EC; Meier A; Julich-Haertel H; Djudjaj S; Rau M; Tschernig T; Geier A; Boor P; Lammert F; Lukacs-Kornek V
J Hepatol; 2017 Jun; 66(6):1241-1250. PubMed ID: 28108233
[TBL] [Abstract][Full Text] [Related]
13. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
14. The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease.
Świderska M; Jaroszewicz J; Stawicka A; Parfieniuk-Kowerda A; Chabowski A; Flisiak R
Clin Exp Hepatol; 2017 Sep; 3(3):127-134. PubMed ID: 29062902
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
16. Mesenteric lymph node CD4
Su L; Wu Z; Chi Y; Song Y; Xu J; Tan J; Cong X; Liu Y
Cell Immunol; 2019 Mar; 337():33-41. PubMed ID: 30770094
[TBL] [Abstract][Full Text] [Related]
17. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.
Rau M; Schilling AK; Meertens J; Hering I; Weiss J; Jurowich C; Kudlich T; Hermanns HM; Bantel H; Beyersdorf N; Geier A
J Immunol; 2016 Jan; 196(1):97-105. PubMed ID: 26621860
[TBL] [Abstract][Full Text] [Related]
18. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
19. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
20. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.
Maricic I; Marrero I; Eguchi A; Nakamura R; Johnson CD; Dasgupta S; Hernandez CD; Nguyen PS; Swafford AD; Knight R; Feldstein AE; Loomba R; Kumar V
J Immunol; 2018 Nov; 201(10):3017-3035. PubMed ID: 30322964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
